| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 338.057 | 307.516 | 285.937 | 289.339 | 276.827 | 319.150 | 256.279 | 520.993 | 967 | 0 |
| Total Income - EUR | 338.112 | 307.563 | 285.980 | 289.709 | 278.273 | 323.385 | 256.280 | 521.090 | 968 | 0 |
| Total Expenses - EUR | 343.265 | 312.246 | 278.876 | 286.373 | 260.664 | 298.655 | 242.912 | 244.931 | 6.295 | 165 |
| Gross Profit/Loss - EUR | -5.153 | -4.682 | 7.104 | 3.335 | 17.609 | 24.730 | 13.367 | 276.159 | -5.327 | -165 |
| Net Profit/Loss - EUR | -5.153 | -4.703 | 4.300 | 425 | 14.804 | 21.686 | 11.188 | 271.144 | -5.327 | -165 |
| Employees | 7 | 5 | 3 | 4 | 4 | 4 | 4 | 3 | 0 | 0 |
Check the financial reports for the company - Phedrafarm Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.848 | 5.042 | 5.092 | 1.680 | 1.369 | 1.252 | 1.225 | 1.228 | 0 | 0 |
| Current Assets | 140.881 | 113.897 | 101.852 | 77.388 | 57.564 | 107.761 | 105.643 | 333.958 | 521 | 392 |
| Inventories | 78.675 | 58.899 | 36.777 | 30.346 | 30.844 | 31.966 | 38.300 | 813 | 0 | 0 |
| Receivables | 59.762 | 44.399 | 61.228 | 46.552 | 26.147 | 74.869 | 66.674 | 319.753 | 384 | 392 |
| Cash | 2.445 | 10.598 | 3.847 | 491 | 574 | 926 | 670 | 13.392 | 137 | 0 |
| Shareholders Funds | -44.647 | -54.437 | -49.216 | -47.887 | -32.156 | -9.861 | 1.546 | 271.193 | -5.133 | -5.269 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 191.376 | 173.376 | 156.160 | 126.956 | 91.090 | 118.875 | 105.322 | 63.993 | 5.654 | 5.662 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Phedrafarm Impex Srl